ampelopsin has been researched along with Escherichia coli Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ishfaq, M; Li, C; Li, R; Li, Y; Liu, F; Shi, C; Si, C; Wang, J; Zhang, R | 1 |
Cao, C; Chang, Y; Li, C; Li, R; Liu, F; Liu, J; Muhammad, I; Shi, C; Yuan, L; Zhang, Y | 1 |
2 other study(ies) available for ampelopsin and Escherichia coli Infections
Article | Year |
---|---|
Dihydromyricetin alleviates Escherichia coli lipopolysaccharide-induced hepatic injury in chickens by inhibiting the NLRP3 inflammasome.
Topics: Animals; Chickens; Escherichia coli; Escherichia coli Infections; Flavonols; Inflammasomes; Lipopolysaccharides; Liver; NLR Family, Pyrin Domain-Containing 3 Protein | 2022 |
Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway.
Topics: Animals; Anti-Bacterial Agents; Chickens; Escherichia coli; Escherichia coli Infections; Female; Flavonols; Ileum; Inflammasomes; Lipopolysaccharides; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Poultry Diseases; Signal Transduction; Toll-Like Receptor 4 | 2020 |